BOV Stock Overview
An energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Apyx Medical Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.33 |
| 52 Week High | US$2.66 |
| 52 Week Low | US$0.89 |
| Beta | 1.21 |
| 11 Month Change | 39.27% |
| 3 Month Change | 20.91% |
| 1 Year Change | -41.67% |
| 33 Year Change | -89.61% |
| 5 Year Change | -81.40% |
| Change since IPO | -77.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| BOV | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 16.7% | 2.4% | 0.8% |
| 1Y | -41.7% | -5.0% | 9.1% |
Return vs Industry: BOV underperformed the German Medical Equipment industry which returned -6.8% over the past year.
Return vs Market: BOV underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| BOV volatility | |
|---|---|
| BOV Average Weekly Movement | 13.2% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: BOV's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: BOV's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 252 | Charlie Goodwin | apyxmedical.com |
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.
Apyx Medical Corporation Fundamentals Summary
| BOV fundamental statistics | |
|---|---|
| Market cap | €51.83m |
| Earnings (TTM) | -€27.10m |
| Revenue (TTM) | €46.25m |
1.1x
P/S Ratio-1.9x
P/E RatioIs BOV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BOV income statement (TTM) | |
|---|---|
| Revenue | US$48.54m |
| Cost of Revenue | US$19.22m |
| Gross Profit | US$29.33m |
| Other Expenses | US$57.77m |
| Earnings | -US$28.44m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.76 |
| Gross Margin | 60.41% |
| Net Profit Margin | -58.59% |
| Debt/Equity Ratio | 302.3% |
How did BOV perform over the long term?
See historical performance and comparison